China’s BRL Gears Up For First CAR-T Trial In Leukemia/Lymphoma - BRL Medicine Inc.

Global | English
- 简体中文
- English
Search

Media Reports

China’s BRL Gears Up For First CAR-T Trial In Leukemia/Lymphoma

2025-08-12 Source:Citeline Company

About Us: About Us; Leadership; Our Culture; News; Join Us; Contact Us

Gene Therapy: Gene Editing Technology Innovation Platform; Hematopoietic Stem Cell Platform

Cell Therapy: Universal Cell Platform; Quikin CAR-T Platform; Enhanced T Cell Platform; In Vivo Gene Editing CAR-T Platform

Follow us on WeChat

Recruitment

Contact Us: Tel： 021-64340008; Email： info@brlmed.com; Address： Science&Technology Park, 3699 Yuanjiang Road, Minhang District, Shanghai

Copyright © 2019 BRL MEDICINE　All Rights Reserved.沪ICP备16011549号 Powered by VTHINK

简体中文

English

Back to top